Financial statements Implon Laboratories
Balance sheet data of IMPLON LABORATORIES
|
Year
|
2018
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 415 695,41 | 57 455,62 | 364 108,27 | 2 513 196,92 | 241 913,35 |
| A. Fixed assets | 0,00 | 0,00 | 0,00 | 350 094,12 | 33 423,66 |
| B. Current assets | 415 695,41 | 57 455,62 | 364 108,27 | 2 163 102,80 | 208 489,69 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | - | - |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | - | - |
| Total liabilities | 415 695,41 | 57 455,62 | 364 108,27 | 2 513 196,92 | 241 913,35 |
| A. Equity | -28 852,26 | -295 387,63 | 36 245,51 | -836 281,32 | -2 207 835,38 |
| B. Liabilities and provisions for liabilities | 444 547,67 | 352 843,25 | 327 862,76 | 3 349 478,24 | 2 449 748,73 |
| I. Long-term liabilities | 0,00 | 238 000,00 | 237 801,75 | 1 348 693,17 | 2 120 406,55 |
| II. Short-term liabilities | 444 547,67 | 114 843,25 | 90 061,01 | 537 542,18 | 329 342,18 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.